AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11872674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial phentolamine (IA PHEN, 12 microg/min per 100 ml forearm tissue)
Number of subjects: 12
Study 11872674 — intervention group
Group type: COMPARATOR
Intervention: Saline (SAL)
Number of subjects: 12
Study 9539464 — intervention group
Group type: EXPERIMENTAL
Intervention: Silica coating/Microfill Pontic C
Number of subjects: 0
Study 9539464 — intervention group
Group type: COMPARATOR
Intervention: Etching/Clearfil F2
Number of subjects: 0
Study 9539464 — intervention group
Group type: COMPARATOR
Intervention: Sandblasting/Panavia EX
Number of subjects: 0
Study 9539464 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified preparation form
Number of subjects: 0
Study 9539464 — intervention group
Group type: COMPARATOR
Intervention: Conventional preparation form
Number of subjects: 0
Study 9539464 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary restorations
Number of subjects: 0
Study 9539464 — intervention group
Group type: COMPARATOR
Intervention: Mandibular restorations
Number of subjects: 0
Study 7623532 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic messages designed to enhance adherence to clinical practice guidelines
Number of subjects: 349
Study 7623532 — intervention group
Group type: COMPARATOR
Intervention: Control group (no electronic messages)
Number of subjects: 349
Study 2717366 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental alcohol intoxication (blood alcohol concentration of at least 0.10%)
Number of subjects: 0
Study 2717366 — intervention group
Group type: COMPARATOR
Intervention: Nonalcohol placebo
Number of subjects: 0
Study 1098132 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of glucose and insulin
Number of subjects: 15
Study 1098132 — intervention group
Group type: COMPARATOR
Intervention: Glucose infusions without insulin
Number of subjects: 15
Study 30334908 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver transplantation
Number of subjects: 147
Study 30334908 — intervention group
Group type: COMPARATOR
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 147
Study 30334908 — intervention group
Group type: COMPARATOR
Intervention: Waiting list patients
Number of subjects: 147
Study 27714435 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator (TO) sling (Monarc™)
Number of subjects: 98
Study 27714435 — intervention group
Group type: COMPARATOR
Intervention: Single incision (SI) sling (MiniArc™)
Number of subjects: 98
Study 25416754 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoster vaccine
Number of subjects: 6867
Study 23077119 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Goals Collaborative Care (LGCC, N = 29)
Number of subjects: 60
Study 23077119 — intervention group
Group type: COMPARATOR
Intervention: Usual care (N = 31)
Number of subjects: 60
Study 21144505 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day)
Number of subjects: 20
Study 21144505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 18083781 — intervention group
Group type: EXPERIMENTAL
Intervention: COX2 inhibition using 200 mg celecoxib once daily for 14 days
Number of subjects: 21
Study 17211118 — intervention group
Group type: EXPERIMENTAL
Intervention: E-Mail educational program
Number of subjects: 99
Study 12930861 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold calling follow-up method
Number of subjects: 210
Study 12930861 — intervention group
Group type: COMPARATOR
Intervention: Letters inviting appointment
Number of subjects: 210
Study 11197785 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (NTG‐TTS)
Number of subjects: 27
Study 11197785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 11197785 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 27
Study 9148337 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole (5 mg/kg/day for 30 days)
Number of subjects: 77
Study 9148337 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifurtimox (5 mg/kg/day for 30 days)
Number of subjects: 77
Study 9148337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 8241095 — intervention group
Group type: EXPERIMENTAL
Intervention: pravastatin 40 mg/d
Number of subjects: 32
Study 8241095 — intervention group
Group type: EXPERIMENTAL
Intervention: fish oil 6 g/d (equivalent to 3 g omega-3 fatty acids/d)
Number of subjects: 32
Study 8241095 — intervention group
Group type: EXPERIMENTAL
Intervention: combined therapy of pravastatin 40 mg/d plus fish oil 6 g/d
Number of subjects: 32
Study 8241095 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study 2862810 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 0
Study 2862810 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0
Study 2862810 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 0
Study 2862810 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 0
Study 31881614 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,4-Diaminobutane (1,4 DAB) 0.8% cream applied once per day at night
Number of subjects: 44
Study 31881614 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,4-Diaminobutane (1,4 DAB) 0.8% cream
Number of subjects: 44
Study 31881614 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (cream base alone)
Number of subjects: 44
Study 30373571 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine pretreatment
Number of subjects: 63
Study 30373571 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine pretreatment
Number of subjects: 63
Study 30373571 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study 26630547 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training (BAL)
Number of subjects: 48
Study 26630547 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates training (PIL)
Number of subjects: 48
Study 26630547 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 48
Study 26541842 — intervention group
Group type: EXPERIMENTAL
Intervention: sitagliptin plus insulin
Number of subjects: 30
Study 26541842 — intervention group
Group type: COMPARATOR
Intervention: placebo plus insulin
Number of subjects: 30
Study 24309198 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (lactobacilli and bifidobacteria, 6 x 10^10 organisms per day for 21 days)
Number of subjects: 2981
Study 24309198 — intervention group
Group type: COMPARATOR
Intervention: Placebo (inert maltodextrin powder)
Number of subjects: 2981
Study 24309198 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 2981
Study 24309198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2981
Study 20510987 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery integrated into usual therapy
Number of subjects: 30
Study 20510987 — intervention group
Group type: COMPARATOR
Intervention: Usual therapy only (Control)
Number of subjects: 30
Study 18688620 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal vein infusion of 5-FU 500 mg/m² plus heparin for 24 hours for seven consecutive days plus mitomycin C 10 mg/m² on the first day
Number of subjects: 753
Study 18688620 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 5-FU 500 mg/m² plus heparin for 24 hours for seven consecutive days plus mitomycin C 10 mg/m² on the first day
Number of subjects: 753
Study 18688620 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 753
Study 16174273 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector system
Number of subjects: 46
Study 16174273 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasonic scaler
Number of subjects: 46
Study 16174273 — intervention group
Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 46
Study 14687818 — intervention group
Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Number of subjects: 43
Study 14687818 — intervention group
Group type: COMPARATOR
Intervention: N-Butyl-2-Cyanoacrylate (cyanoacrylate) glue injection
Number of subjects: 43
Study 10732933 — intervention group
Group type: EXPERIMENTAL
Intervention: Let Me Decide advance directive program
Number of subjects: 1292
Study 8819502 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg cocaine
Number of subjects: 12
Study 8819502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1544117 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy
Number of subjects: 0
Study 1544117 — intervention group
Group type: COMPARATOR
Intervention: Total mastectomy
Number of subjects: 0
Study 1544117 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy followed by radiation therapy
Number of subjects: 0
Study 1544117 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple operations
Number of subjects: 0
Study 3899951 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral verapamil 40 mg three times daily
Number of subjects: 100
Study 3899951 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antiarrhythmic agents)
Number of subjects: 100
Study 31907186 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-Amodiaquine (200 mg AS/540 mg AQ) plus Methylene Blue (325 mg)
Number of subjects: 15
Study 31907186 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-Amodiaquine plus Methylene Blue
Number of subjects: 15
Study 31907186 — intervention group
Group type: COMPARATOR
Intervention: Artesunate-Amodiaquine
Number of subjects: 15
Study 29458933 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body cryotherapy (10 sessions over 8 days, in addition to usual care)
Number of subjects: 24
Study 29458933 — intervention group
Group type: COMPARATOR
Intervention: Control group (no change in everyday activities)
Number of subjects: 24
Study 26713665 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 weeks of preoperative progressive resistance training (PRT)
Number of subjects: 59
Study 26713665 — intervention group
Group type: COMPARATOR
Intervention: 4 weeks of postoperative PRT only (control group)
Number of subjects: 59
Study 26713665 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 59
Study 24668008 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplanted kidneys
Number of subjects: 12
Study 24668008 — intervention group
Group type: COMPARATOR
Intervention: Transplanted kidneys with normal function
Number of subjects: 12
Study 22206795 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg
Number of subjects: 43
Study 22206795 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg under fed conditions
Number of subjects: 43
Study 22206795 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg under fasted conditions
Number of subjects: 43
Study 22206795 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 800 mg
Number of subjects: 43
Study 22206795 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib (various doses in Study A)
Number of subjects: 43
Study 22206795 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib (all doses)
Number of subjects: 43
Study 22206795 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib (all studies)
Number of subjects: 43
Study 20124784 — intervention group
Group type: EXPERIMENTAL
Intervention: Botox
Number of subjects: 57
Study 20124784 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosigne
Number of subjects: 57
Study 17196712 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine (16-24 mg/day)
Number of subjects: 18
Study 17196712 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 16225930 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% motor threshold (MT) rTMS
Number of subjects: 54
Study 16225930 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% motor threshold (MT) rTMS
Number of subjects: 54
Study 16225930 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 54
Study 12364632 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 36
Study 12364632 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg CDP870 (n = 8)
Number of subjects: 36
Study 12364632 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg CDP870 (n = 8)
Number of subjects: 36
Study 12364632 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg CDP870 (n = 8)
Number of subjects: 36
Study 12364632 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment effect of CDP870 (0, 1, 5, 20 mg/kg)
Number of subjects: 36
Study 12364632 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label infusion of 5 or 20 mg/kg CDP870 (n = 32)
Number of subjects: 36
Study 10856808 — intervention group
Group type: EXPERIMENTAL
Intervention: Class II copy-milled ceramic inlays
Number of subjects: 101
Study 10856808 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory stage for Class II copy-milled ceramic inlays
Number of subjects: 101
Study 10856808 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavity modification technique (composite basing/conventional)
Number of subjects: 101
Study 10856808 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical operator (seven dentists)
Number of subjects: 101
Study 10856808 — intervention group
Group type: EXPERIMENTAL
Intervention: Size of the restoration (large/medium)
Number of subjects: 101
Study 10856808 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall working time for Class II copy-milled ceramic inlays
Number of subjects: 101
Study 10856808 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentists' efficiency over time
Number of subjects: 101
Study 10856808 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory time for inlay production
Number of subjects: 101
Study 9327688 — intervention group
Group type: EXPERIMENTAL
Intervention: Injections before 90 minutes (mean 2.46 ± 1.78; n = 94)
Number of subjects: 389
Study 9327688 — intervention group
Group type: EXPERIMENTAL
Intervention: Injections before 90 minutes (mean 2.71 ± 2.42; n = 295)
Number of subjects: 389
Study 9327688 — intervention group
Group type: EXPERIMENTAL
Intervention: Injections before 90 minutes (mean 2.53 ± 2.53; n = 184)
Number of subjects: 389
Study 9327688 — intervention group
Group type: EXPERIMENTAL
Intervention: Injections before 90 minutes (mean 2.76 ± 2.03; n = 204)
Number of subjects: 389
Study 8452276 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg/kg bolus followed by infusion of 1 micrograms.kg‐1 x min‐1
Number of subjects: 50
Study 8452276 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.2 mg/kg bolus followed by infusion of 2 micrograms.kg‐1 x min‐1
Number of subjects: 50
Study 8452276 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.4 mg/kg bolus followed by infusion of 4 micrograms.kg‐1 x min‐1
Number of subjects: 50
Study 8452276 — intervention group
Group type: COMPARATOR
Intervention: No midazolam (Control)
Number of subjects: 50
Study 3725003 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline, 50 mg
Number of subjects: 15
Study 3725003 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 15
Study 3725003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 29975270 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH)
Number of subjects: 156
Study 29975270 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous needle fasciotomy (PNF)
Number of subjects: 156
Study 29975270 — intervention group
Group type: COMPARATOR
Intervention: Both CCH and PNF
Number of subjects: 156
Study 27710821 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin
Number of subjects: 382
Study 27710821 — intervention group
Group type: COMPARATOR
Intervention: voglibose
Number of subjects: 382
Study 24495514 — intervention group
Group type: EXPERIMENTAL
Intervention: Stop Delirium! intervention delivered over 16 months
Number of subjects: 14
Study 24495514 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 14
Study 23409601 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination training group (1 x 9 reps with 3-kg medicine ball, followed by 3 x 14 reps with water polo ball)
Number of subjects: 30
Study 23409601 — intervention group
Group type: COMPARATOR
Intervention: Medicine-ball training group (3 x 6 reps with 3-kg medicine ball)
Number of subjects: 30
Study 20634482 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent-adjuvant chemotherapy (CRT) with cisplatin (100 mg/m² every 3 weeks for three cycles) plus radiotherapy
Number of subjects: 348
Study 20634482 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent-adjuvant chemotherapy (CRT) with cisplatin plus radiotherapy
Number of subjects: 348
Study 20634482 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent-adjuvant chemotherapy (CRT)
Number of subjects: 348
Study 20634482 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (RT)
Number of subjects: 348
Study 18546762 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct composite resin core-crown reconstruction with a prefabricated metal post
Number of subjects: 87
Study 18546762 — intervention group
Group type: COMPARATOR
Intervention: Direct composite resin core-crown reconstruction without a post (post-free)
Number of subjects: 87
Study 16473223 — intervention group
Group type: EXPERIMENTAL
Intervention: LASIK treatment (bilateral, same-day)
Number of subjects: 59
Study 16473223 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-LASIK treatment (surgical emmetropes)
Number of subjects: 59
Study 16473223 — intervention group
Group type: COMPARATOR
Intervention: Myopes not seeking refractive surgery (control group)
Number of subjects: 59
Study 16473223 — intervention group
Group type: COMPARATOR
Intervention: Natural emmetropes
Number of subjects: 59
Study 12414404 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat LASIK
Number of subjects: 33
Study 12414404 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (>66 micro m) after primary LASIK
Number of subjects: 33
Study 10502590 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydroepiandrosterone (50 mg orally each morning for four months)
Number of subjects: 24
Study 10502590 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily for four months)
Number of subjects: 24
Study 8595540 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol, 50 microgram twice daily
Number of subjects: 134
Study 8595540 — intervention group
Group type: COMPARATOR
Intervention: Disodium cromoglycate, 20 mg four times daily
Number of subjects: 134
Study 1955633 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn (20 mg via nebulizer, three times per day)
Number of subjects: 31
Study 1955633 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (inhaled corticosteroid, dosage not specified, three times per day)
Number of subjects: 31
Study 1955633 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for both Cromolyn and Triamcinolone)
Number of subjects: 31
Study 29306867 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening by Lugol chromoendoscopy
Number of subjects: 33948
Study 29306867 — intervention group
Group type: COMPARATOR
Intervention: No screening (Control)
Number of subjects: 33948
Study 28611102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular gentamicin and oral amoxicillin for 7 days at health posts
Number of subjects: 1011
Study 28611102 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 1011
Study 28611102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm
Number of subjects: 1011
Study 25099730 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (32-34 °C)
Number of subjects: 148
Study 25099730 — intervention group
Group type: COMPARATOR
Intervention: Fever control (35.5-37 °C)
Number of subjects: 148
Study 23663487 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinna in forward position
Number of subjects: 18
Study 23663487 — intervention group
Group type: COMPARATOR
Intervention: Pinna in backward position
Number of subjects: 18
Study 21878034 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) prior to Cognitive Behavioural Therapy (CBT)
Number of subjects: 35
Study 21878034 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 35
Study 21878034 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioural Therapy (CBT) alone
Number of subjects: 35
Study 21878034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 35
Study 19287017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 735
Study 19287017 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 735
Study 18186171 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.454% stabilized SnF2 sodium hexametaphosphate dentifrice
Number of subjects: 75
Study 18186171 — intervention group
Group type: COMPARATOR
Intervention: Sodium fluoride dentifrice (control)
Number of subjects: 75
Study 15028439 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic protocol (40 mg mitomycin-C)
Number of subjects: 52
Study 15028439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablative protocol (80 mg mitomycin-C)
Number of subjects: 52
Study 15028439 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined chemo-thermotherapy
Number of subjects: 52
Study 11842896 — intervention group
Group type: EXPERIMENTAL
Intervention: G115 400 mg
Number of subjects: 20
Study 11842896 — intervention group
Group type: EXPERIMENTAL
Intervention: G115 200 mg
Number of subjects: 20
Study 11842896 — intervention group
Group type: EXPERIMENTAL
Intervention: G115 600 mg
Number of subjects: 20
Study 11842896 — intervention group
Group type: EXPERIMENTAL
Intervention: G115 200 mg and 400 mg
Number of subjects: 20
Study 11842896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9712239 — intervention group
Group type: EXPERIMENTAL
Intervention: T cells expanded from the colon of patients with Crohn's disease (CD)
Number of subjects: 43
Study 9712239 — intervention group
Group type: EXPERIMENTAL
Intervention: T cells expanded from the colon of patients with ulcerative colitis (UC)
Number of subjects: 43
Study 9712239 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 43